Stefano Lancellotti

1.8k total citations
51 papers, 1.2k citations indexed

About

Stefano Lancellotti is a scholar working on Hematology, Immunology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Stefano Lancellotti has authored 51 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Hematology, 21 papers in Immunology and 8 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Stefano Lancellotti's work include Platelet Disorders and Treatments (22 papers), Complement system in diseases (20 papers) and Blood Coagulation and Thrombosis Mechanisms (12 papers). Stefano Lancellotti is often cited by papers focused on Platelet Disorders and Treatments (22 papers), Complement system in diseases (20 papers) and Blood Coagulation and Thrombosis Mechanisms (12 papers). Stefano Lancellotti collaborates with scholars based in Italy, United States and Japan. Stefano Lancellotti's co-authors include Raimondo De Cristofaro, Maria Sole Basso, Enrico Di Stasio, Maurizio Pompili, Laura Riccardi, Maria Assunta Zocco, Francesca Romana Ponziani, Paolo Tondi, Raffaele Landolfi and Roberto Flore and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Stefano Lancellotti

47 papers receiving 1.2k citations

Peers

Stefano Lancellotti
Stefano Lancellotti
Citations per year, relative to Stefano Lancellotti Stefano Lancellotti (= 1×) peers Maria Cecília S. Freitas

Countries citing papers authored by Stefano Lancellotti

Since Specialization
Citations

This map shows the geographic impact of Stefano Lancellotti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefano Lancellotti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefano Lancellotti more than expected).

Fields of papers citing papers by Stefano Lancellotti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefano Lancellotti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefano Lancellotti. The network helps show where Stefano Lancellotti may publish in the future.

Co-authorship network of co-authors of Stefano Lancellotti

This figure shows the co-authorship network connecting the top 25 collaborators of Stefano Lancellotti. A scholar is included among the top collaborators of Stefano Lancellotti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefano Lancellotti. Stefano Lancellotti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Fianchi, Luana, Alessandra Borchiellini, Gaetano Giuffrida, et al.. (2024). Real-World Data on Effectiveness and Safety of First-Line Use of Caplacizumab in Italian Centers for the Treatment of Thrombotic Thrombocytopenic Purpura: The Roscapli Study. Journal of Clinical Medicine. 13(21). 6561–6561.
3.
Lancellotti, Stefano, et al.. (2023). Immune and Hereditary Thrombotic Thrombocytopenic Purpura: Can ADAMTS13 Deficiency Alone Explain the Different Clinical Phenotypes?. Journal of Clinical Medicine. 12(9). 3111–3111. 4 indexed citations
4.
Lancellotti, Stefano, et al.. (2023). Commentary on “Structural analyses of β2-glycoprotein I: is there a circular conformation?”. Journal of Thrombosis and Haemostasis. 21(12). 3354–3356. 1 indexed citations
5.
Lancellotti, Stefano, et al.. (2023). Measurement of extended half-life recombinant FVIII molecules: In vitro and ex vivo evidence of relevant assay discrepancies. Research and Practice in Thrombosis and Haemostasis. 7(2). 100070–100070. 2 indexed citations
6.
Lancellotti, Stefano, Alessio Branchini, Maria Francesca Testa, et al.. (2022). The p.P1127S pathogenic variant lowers von Willebrand factor levels through higher affinity for the macrophagic scavenger receptor LRP1: Clinical phenotype and pathogenic mechanisms. Journal of Thrombosis and Haemostasis. 20(8). 1818–1829. 4 indexed citations
7.
Ranalli, Paola, Stefano Lancellotti, Giovanna Petrucci, et al.. (2020). Increased von Willebrand factor levels in polycythemia vera and phenotypic differences with essential thrombocythemia. Research and Practice in Thrombosis and Haemostasis. 4(3). 413–421. 11 indexed citations
8.
Lancellotti, Stefano, et al.. (2016). Presence of portal vein thrombosis in liver cirrhosis is strongly associated with low levels of ADAMTS-13: a pilot study. Internal and Emergency Medicine. 11(7). 959–967. 33 indexed citations
9.
Lancellotti, Stefano, Alfredo Dragani, Paola Ranalli, et al.. (2015). Qualitative and quantitative modifications of von Willebrand factor in patients with essential thrombocythemia and controlled platelet count. Journal of Thrombosis and Haemostasis. 13(7). 1226–1237. 46 indexed citations
10.
Lancellotti, Stefano, Maria Sole Basso, & Raimondo De Cristofaro. (2013). PROTEOLYTIC PROCESSING OF VON WILLEBRAND FACTOR BY ADAMTS13 AND LEUKOCYTE PROTEASES. Mediterranean Journal of Hematology and Infectious Diseases. 5(1). e2013058–e2013058. 14 indexed citations
11.
Scaglione, Giovanni Luca, Stefano Lancellotti, Massimiliano Papi, et al.. (2013). The type 2B p.R1306W natural mutation of von Willebrand factor dramatically enhances the multimer sensitivity to shear stress. Journal of Thrombosis and Haemostasis. 11(9). 1688–1698. 13 indexed citations
12.
Lancellotti, Stefano & Raimondo De Cristofaro. (2011). Structure and Proteolytic Properties of ADAMTS13, A Metalloprotease Involved in the Pathogenesis of Thrombotic Microangiopathies. Progress in molecular biology and translational science. 99. 105–144. 11 indexed citations
13.
Papi, Massimiliano, Giuseppe Maulucci, Marco De Spirito, et al.. (2010). Ristocetin-induced self-aggregation of von Willebrand factor. European Biophysics Journal. 39(12). 1597–1603. 24 indexed citations
14.
Petrucci, Giovanna, Raimondo De Cristofaro, Sergio Rutella, et al.. (2010). Prostaglandin E2 Differentially Modulates Human Platelet Function through the Prostanoid EP2 and EP3 Receptors. Journal of Pharmacology and Experimental Therapeutics. 336(2). 391–402. 35 indexed citations
15.
Stasio, Enrico Di, Federica Romitelli, Stefano Lancellotti, et al.. (2009). Kinetic study of von Willebrand factor self-aggregation induced by ristocetin. Biophysical Chemistry. 144(3). 101–107. 14 indexed citations
16.
Lancellotti, Stefano, Vincenzo De Filippis, Nicola Pozzi, et al.. (2009). Formation of methionine sulfoxide by peroxynitrite at position 1606 of von Willebrand factor inhibits its cleavage by ADAMTS-13: A new prothrombotic mechanism in diseases associated with oxidative stress. Free Radical Biology and Medicine. 48(3). 446–456. 53 indexed citations
17.
Lancellotti, Stefano & Raimondo De Cristofaro. (2009). Congenital Prothrombin Deficiency. Seminars in Thrombosis and Hemostasis. 35(4). 367–381. 37 indexed citations
18.
Zocco, Maria Assunta, Enrico Di Stasio, Raimondo De Cristofaro, et al.. (2009). Thrombotic risk factors in patients with liver cirrhosis: Correlation with MELD scoring system and portal vein thrombosis development. Journal of Hepatology. 51(4). 682–689. 331 indexed citations
19.
Aprile, Irene, Enrico Di Stasio, Federica Romitelli, et al.. (2008). Effects of rehabilitation on quality of life in patients with chronic stroke. Brain Injury. 22(6). 451–456. 33 indexed citations
20.
Aprile, Irene, Federica Romitelli, D B Piazzini, et al.. (2008). Effects of rehabilitation treatment on thyroid function. Clinical Endocrinology. 70(4). 644–649. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026